CVRX Earnings

CVRX reported its FY2025Q4 earnings on 2026-02-10, showcasing a revenue of 0.00 against an estimate of 15.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.42 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CVRX's FY2025Q4 earnings announcement on 2026-02-10, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, CVRX's stock price tends to shift by an average of -1.45% in the 10 days leading up to earnings and -4.39% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate CVRX’s annual revenue to reach 16.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Revise Downward by -1.36% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CVRX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Revise Downward by -1.36% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CVRX's stock price typically moves by -1.45% in the 10 days before its earnings and -4.39% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 16.00M.

The earnings call summary presents mixed signals. The financial performance shows a slight improvement in net loss per share, and cash reserves are healthy. However, guidance was cut on the higher end, and sales force productivity is not fully realized. The Q&A reveals cautious optimism, with potential growth in 2026 but conservative Q4 guidance. There are positive developments in gross margin and reimbursement, but uncertainties in productivity improvements and market expansion remain. Without a market cap, the overall sentiment is neutral, expecting minimal stock movement.